| Date Filed | Type | Description |
| 08/15/2023 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1584, valued at
$171.5k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,246 shares
@ $0 |
|
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2019 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,920 shares
@ $0
Sold 787 shares
@ $135.6504, valued at
$106.8k
Granted 4,805 options to buy
@ $137.12, valued at
$658.9k
|
|
| 08/13/2018 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,495 shares
@ $0
Sold 715 shares
@ $176.6106, valued at
$126.3k
Granted 3,735 options to buy
@ $177.73, valued at
$663.8k
|
|
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/11/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/14/2015 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 697 shares
@ $173.85, valued at
$121.2k
Sold 7 shares
@ $175.15, valued at
$1.2k
|
|
| 08/11/2014 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,650 shares
@ $0
Granted 3,300 options to buy
@ $135.44, valued at
$447k
|
|
| 05/13/2013 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 4,000 shares
@ $0
Granted 8,000 options to buy
@ $55.28, valued at
$442.2k
|
|
| 05/09/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |